Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.
Saved in:
| Title: | Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study. |
|---|---|
| Authors: | Fukuhara, Noriko1 (AUTHOR), Yamamoto, Go2 (AUTHOR), Tsujimura, Hideki3 (AUTHOR), Chou, Takaaki4 (AUTHOR), Shibayama, Hirohiko5 (AUTHOR), Yanai, Tomoko6 (AUTHOR), Shibuya, Kazunori6 (AUTHOR), Izutsu, Koji7 (AUTHOR) kizutsu@ncc.go.jp |
| Source: | Leukemia & Lymphoma. Jan2020, Vol. 61 Issue 1, p176-180. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
